For research use only
| Cat No. | ABC-RC008Y |
| Product Type | Reporter Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Mouse |
| Host Cell | KLN205 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Storage | Liquid Nitrogen |
KLN205 SMAD/TGF β Reporter (Luc) Stable Cell Line by AcceGen enables quantitative bioluminescent monitoring of SMAD/TGF β signaling in cancer research.
KLN205 SMAD/TGF β Reporter (Luc) Stable Cell Line is a bioluminescent reporter model engineered from murine lung squamous carcinoma KLN205 cells, featuring stable integration of a luciferase gene driven by SMAD-responsive promoter elements. This system allows sensitive, quantitative monitoring of TGF β pathway activation through luciferase expression, while preserving the epithelial morphology and tumorigenic features of parental KLN205 cells. The luciferase reporter provides a robust platform for tracking SMAD/TGF β signaling dynamics in response to ligands such as TGF β1 and BMPs, or pharmacological modulators. Applications include studies of epithelial–mesenchymal transition (EMT), tumor–microenvironment interactions, high-throughput drug screening, and preclinical evaluation of TGF β-targeting therapeutics. All cells are rigorously quality controlled and confirmed negative for mycoplasma, fungi, yeast, and bacteria.
| Species | Mouse |
| Cat.No | ABC-RC008Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Reporter Stable Cell Lines |
| Host Cell | KLN205 |
| Gene Info | Luciferase (SMAD / TGF β-responsive reporter) |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The KLN205 SMAD/TGF β Reporter (Luc) Stable Cell Line is designed for sensitive monitoring of TGF β signaling through luciferase expression. This bioluminescent system enables quantitative, real-time assessment of SMAD-mediated transcriptional activity in response to TGF β stimulation, supporting studies on TGF β’s dual role in tumor suppression and progression. It is particularly useful for drug screening, EMT research, and tumor–microenvironment analysis in lung squamous carcinoma models.